ArticleParasitology research2015
Identification criteria of the rare multi-flagellate Lophomonas blattarum: comparison of different staining techniques.
Article in Parasitology research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Frequency, Demographic and Clinical Characteristics of Pediatric Lophomoniasis: A Cross-Sectional Study in Northern Iran.Pediatric pulmonology · 2026Article
- Development and Validation of In-House Conventional and Multiplex PCR Methods for the Detection and Identification of Lophomonas spp.: An Innovative Approach.Journal of clinical laboratory analysis · 2025Article
- Effect of Antibiotic Therapy againstTanaffos · 2025Article
- Misidentification of Lophomonas Blattarum: Methodological Flaws and Taxonomic Confusion in Molecular Diagnostics.Advanced biomedical research · 2025Article
- Parasitological and molecular study ofArchives of Razi Institute · 2024Article
- Characterization ofInfectious disease reports · 2024Article
- Case series of complicated bronchopulmonary lophomoniasis. Differential diagnosis of tuberculosis?European clinical respiratory journal · 2024Article
- Prevalence, socio-economic, and associated risk factors of oral cavity parasites in children with intellectual disability from Lorestan province, Iran.Frontiers in cellular and infection microbiology · 2024Article
- Lophomonas blattarum-like organism in bronchoalveolar lavage from a pneumonia patient: current diagnostic scheme and polymerase chain reaction can lead to false-positive results.Parasites, hosts and diseases · 2023Article
- Geospatial Analysis and Molecular Epidemiologic Study of Emerging Pulmonary Lophomoniasis in Iran: A National Registry-Based Study.Journal of parasitology research · 2023Article
- Molecular evidence of upper and lower respiratory infection due toClinical case reports · 2022Article
- Effective Treatment of Chronic Cough with Tinidazole as the Newest Antiprotozoa againstJournal of parasitology research · 2022Article
- Global Status of EmergingInterdisciplinary perspectives on infectious diseases · 2022Review
- Morphological and Molecular Identification of Emerged Lophomonas blattarum Infection in Mazandaran Province, Northern Iran: First Registry-Based Study.Acta parasitologica · 2021Article
- First report ofJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2021Article
- Bronchopulmonary lophomoniasis: A rare cause of pneumonia in an immunosuppressed host.Respiratory medicine case reports · 2019Article
- The prevalence of protozoa in the gut of German cockroaches (Blattella germanica) with special reference to Lophomonas blattarum.Parasitology research · 2017Article
- Bronchopulmonary infection byJournal of thoracic disease · 2017Article
- Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bronchopulmonary lophomoniasis (BPL) is an emerging disease of potential importance. BPL is presented by non-specific clinical picture and is usually accompanied by immunosuppression. Culture of Lophomonas blattarum is difficult and its molecular diagnosis has not yet been developed. Therefore, microscopic examination of respiratory samples, e.g., bronchoalveolar lavage (BAL) or sputum, is the mainstay of BPL diagnosis. Creola bodies and ciliocytophthoria are two forms of bronchial cells which occur in chest diseases with non-specific clinical picture like that of BPL. Both forms could be misrecognized as multi-flagellates because of their motile cilia in the wet mounts and due to shape variability of L. blattarum in stained smears. The aim of the study is to compare different staining techniques for visualizing L. blattarum to improve the recognition and diagnosis of BPL, to distinguish respiratory epithelial cells from L. blattarum and to decide which stain is recommended in suspected cases of BPL. BAL samples from patients which contain L. blattarum, creola bodies, and ciliocytophthoria were collected then wet mounts were examined. The BAL samples were also stained by Papanicolaou (PAP), Giemsa, hematoxylin and eosin (H & E), trichrome, Gram, and Diff-Quik (DQ) stains. The different staining techniques were compared regarding the stain quality. In wet mounts, the ciliary movement was coordinate and synchronous while the flagellar movement was wavy and leaded to active swimming of L. blattarum. In stained slides, bronchial cells were characterized by the presence of basal nucleus and the terminal bar from which the cilia arise. Trichrome was the best stain in demonstration of cellular details of L. blattarum. H & E, PAP, and Giemsa stains showed good quality of stains. Gram and DQ stains showed only pale hues of L. blattarum. We recommended adding Wheatley's trichrome staining to the differential diagnosis workup of cases of non-specific chest infections, especially when BPL is suspected, to avoid overdiagnosis or underdiagnosis of it.
Indexed as
Identifiers
26032944What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.